COVID-19 vaccination in patients with cancer receiving immune checkpoint inhibitors: a systematic review and meta-analysis

BACKGROUND: Immune checkpoint inhibitors (ICI) can cause off-target inflammatory and immune-related adverse events (irAE). Conceivably, COVID-19 vaccination could trigger an inflammatory and immune response that could induce or aggravate irAE. METHODS: The objective of this systematic review is to a...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruiz, Juan Ignacio, Lopez-Olivo, Maria Angeles, Geng, Yimin, Suarez-Almazor, Maria E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Clinical/Translational Cancer Immunotherapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9905786/
https://www.ncbi.nlm.nih.gov/pubmed/36746512
http://dx.doi.org/10.1136/jitc-2022-006246

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9905786/
https://www.ncbi.nlm.nih.gov/pubmed/36746512
http://dx.doi.org/10.1136/jitc-2022-006246

Ejemplares similares